bacteriostatic sodium chloride

Generic: sodium chloride

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bacteriostatic sodium chloride
Generic Name sodium chloride
Labeler fresenius kabi usa, llc
Dosage Form INJECTION
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active Ingredients

sodium chloride 9 mg/mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 63323-924
Product ID 63323-924_d83b23bf-9f14-4e45-a569-b227cbb08e88
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA088911
Listing Expiration 2026-12-31
Marketing Start 2000-08-08

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63323924
Hyphenated Format 63323-924

Supplemental Identifiers

RxCUI
313002
UNII
451W47IQ8X

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bacteriostatic sodium chloride (source: ndc)
Generic Name sodium chloride (source: ndc)
Application Number ANDA088911 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 9 mg/mL
source: ndc
Packaging
  • 25 VIAL, MULTI-DOSE in 1 TRAY (63323-924-10) / 10 mL in 1 VIAL, MULTI-DOSE (63323-924-01)
  • 25 VIAL, MULTI-DOSE in 1 TRAY (63323-924-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-924-03)
source: ndc

Packages (2)

63323-924-10 25 VIAL, MULTI-DOSE in 1 TRAY (63323-924-10) / 10 mL in 1 VIAL, MULTI-DOSE (63323-924-01) 63323-924-30 25 VIAL, MULTI-DOSE in 1 TRAY (63323-924-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-924-03)

Ingredients (1)

sodium chloride (9 mg/mL)

Linked Drug Pages (1)

Bacteriostatic Sodium Chloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "d83b23bf-9f14-4e45-a569-b227cbb08e88", "openfda": {"unii": ["451W47IQ8X"], "rxcui": ["313002"], "spl_set_id": ["e5e325d1-0d58-40c9-9645-3ae402ff9d92"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, MULTI-DOSE in 1 TRAY (63323-924-10)  / 10 mL in 1 VIAL, MULTI-DOSE (63323-924-01)", "package_ndc": "63323-924-10", "marketing_start_date": "20000808"}, {"sample": false, "description": "25 VIAL, MULTI-DOSE in 1 TRAY (63323-924-30)  / 30 mL in 1 VIAL, MULTI-DOSE (63323-924-03)", "package_ndc": "63323-924-30", "marketing_start_date": "20000808"}], "brand_name": "Bacteriostatic Sodium Chloride", "product_id": "63323-924_d83b23bf-9f14-4e45-a569-b227cbb08e88", "dosage_form": "INJECTION", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]"], "product_ndc": "63323-924", "generic_name": "SODIUM CHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bacteriostatic Sodium Chloride", "active_ingredients": [{"name": "SODIUM CHLORIDE", "strength": "9 mg/mL"}], "application_number": "ANDA088911", "marketing_category": "ANDA", "marketing_start_date": "20000808", "listing_expiration_date": "20261231"}